Interventions to improve glycemic control reduce the progression of diabetic retinopathy.1 Additionally, pharmacologic reduction of blood pressure (BP) in patients with diabetes mellitus and poorly controlled hypertension reduces the risk of worsening diabetic retinopathy.2 Despite pharmacologic improvements, hypertension remains poorly controlled in approximately half of Americans with it.3 The Hypertension Intervention Nurse Telemedicine Study (HINTS) investigated a telemedicine-mediated medication management and behavioral intervention for hypertension. Participants in HINTS (including nondiabetic individuals) with poor BP control who received combined medication and behavioral management demonstrated mean decreases in systolic BP of 15 mm Hg and 8 mm Hg at 12 and 18 months, respectively.4 The purpose of the current analysis was to determine whether the interventions influenced the progression of diabetic retinopathy in participants with diabetes.
Eligibility criteria for HINTS included veterans having hypertension with inadequate BP control (average BP in past 12 months >140/80 mm Hg). Patients were excluded for hemodialysis or a creatinine level greater than 2.5 mg/dL (to convert to micromoles per liter, multiply by 88.4). All participants received home BP monitors. Participants were randomized to the following: (1) usual care; (2) nurse-administered behavioral intervention; (3) nurse-administered medication management; or (4) a combination of the 2 interventions (Table). In institutional review board–approved secondary analyses of diabetic participants, a single chart abstractor (K.W.M.) determined the presence and severity of diabetic retinopathy at baseline and the most recent follow-up, as recorded by the eye care provider of record in the electronic chart. Eligible participants had at least 1 documented dilated examination prior to or within 2 months of enrollment and at least 1 subsequent dilated examination 365 days or later following enrollment. Progression was defined as one or both eyes moving 1 or more steps along the spectrum of retinopathy: none, mild nonproliferative, moderate nonproliferative, severe nonproliferative, proliferative, and visual acuity less than 20/60 in the better-seeing eye. Logistic regression was used to examine the association between progression of diabetic retinopathy and the intervention group, adjusting for baseline hypertension control and duration of follow-up.
Of the 593 veterans enrolled in HINTS, 252 were identified as diabetic. Of the 194 participants meeting the additional criteria for documented eye examinations, 58 (30%) had diabetic retinopathy at baseline and 65 (34%) experienced progression of retinopathy in at least 1 eye at follow-up (mean [SD] follow-up, 1255  days; median follow-up, 1310 days). After controlling for duration of follow-up, the odds of diabetic retinopathy progression were significantly greater among participants receiving usual care than among participants receiving medication management, either alone or in combination with behavioral management (odds ratio = 2.16; 95% CI, 1.03-4.52; P = .04), but not different from the group receiving behavioral management alone (odds ratio = 0.88; 95% CI, 0.40-1.95; P = .84).
A nurse-administered medication management program facilitated by home BP monitoring was associated with decreased risk of progression of retinopathy in diabetic individuals with comorbid hypertension. Although intensive pharmacologic control of systolic BP (<120 mm Hg) may not be protective against worsening diabetic retinopathy,5 the more moderate reduction in systolic BP achieved in HINTS via the nurse-administered telemedicine program4 (8 mm Hg lower in the combined intervention group vs the control group) may offer greater benefit. Telemedicine also has the potential advantage of reaching patients with suboptimal access to traditional care. Diabetic individuals with renal disease were excluded from HINTS, likely limiting the population to diabetic individuals with less severe retinopathy. As such, the results of this study are consistent with other work suggesting that BP control is most helpful in controlling diabetic retinopathy in early disease.6 Although as a secondary analysis this study is limited in the ability to support causation (for example, less progression of retinopathy in the combined intervention group may be related to the intervention but not a direct result of decreasing BP), the potential benefit of telemedicine interventions targeting BP control in patients at risk for diabetic eye disease is encouraging and warrants further study.
Corresponding Author: Dr Muir, Department of Ophthalmology, Duke University Medical Center, PO Box 3802, Durham, NC 27710 (email@example.com).
Published Online: May 23, 2013. doi: 10.1001/jamaophthalmol.2013.81
Conflict of Interest Disclosures: None reported.
Trial Registration: clinicaltrials.gov Identifier: NCT00129103.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Ophthalmology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Original Article: Does This Patient Have a Hemorrhagic Stroke?
The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.